Suppr超能文献

妊娠期及产后甲状腺功能减退症的全国检测现状。

National status of testing for hypothyroidism during pregnancy and postpartum.

机构信息

Quest Diagnostics, West Norriton, PA 19403, USA.

出版信息

J Clin Endocrinol Metab. 2012 Mar;97(3):777-84. doi: 10.1210/jc.2011-2038. Epub 2011 Dec 14.

Abstract

CONTEXT

Hypothyroidism, overt or subclinical, is associated with adverse outcomes for pregnant women and their offspring. Knowledge of current national thyroid testing rates and positivity during pregnancy is limited.

OBJECTIVE

The aim of the study was to estimate thyroid testing rate and positivity during pregnancy and postpartum, including testing and positivity rates of thyroperoxidase antibody (TPO Ab) and free T(4) tests in pregnant women with elevated TSH levels (hypothyroid), and in pregnant women having TSH within range (euthyroid).

DESIGN AND SETTING

Records from a large, national sample of pregnant women screened from June 2005 through May 2008 were examined.

PARTICIPANTS

The study included 502,036 pregnant women, for whom gestational age information was available.

MAIN MEASURES

Testing rates and the prevalence of hypothyroidism during pregnancy and postpartum were measured using assay-specific, trimester-specific reference intervals. Screening and positivity rates of TPO Ab and free T(4) tests were also measured.

RESULTS

Of women ages 18 to 40 yr, 23% (117,892 of 502,036) were tested for gestational hypothyroidism (defined as both subclinical and overt hypothyroidism). Of these, 15.5% (18,291 of 117,892) tested positive for gestational hypothyroidism. Twenty-four percent (22,650 of 93,312) of women with TSH within range and 33% (6,072 of 18,291) of women with elevated TSH were also tested for gestational hypothyroxinemia. Gestational hypothyroxinemia was seen in 0.2% (47 of 22,650) of the tested women with TSH within range and was seen in 2.4% (144 of 6,072) of the tested women having elevated TSH; 0.3% (276 of 93,312) of women with TSH within range received a TPO Ab test, and of these, 15% (41 of 276) tested positive; 0.66% (120 of 18,291) of women with elevated TSH received a TPO Ab test, and of these, 65% (78 of 120) tested positive. Only 20.7% (1873 of 9063) of hypothyroid women received thyroid screening within 6 months postpartum; of these, 11.5% (215 of 1873) were diagnosed with postpartum hypothyroidism.

CONCLUSION

Gestational hypothyroidism is more common than generally acknowledged. Testing is not common, and test selection is variable. There is a low rate of postpartum follow-up.

摘要

背景

甲状腺功能减退症(显性或亚临床)与孕妇及其后代的不良结局有关。目前关于全国范围内甲状腺检测率和妊娠期间阳性率的知识有限。

目的

本研究旨在评估妊娠和产后的甲状腺检测率和阳性率,包括对促甲状腺激素(TSH)水平升高(甲状腺功能减退症)的孕妇和 TSH 水平正常(甲状腺功能正常)的孕妇进行甲状腺过氧化物酶抗体(TPOAb)和游离 T4 检测的检测率和阳性率。

设计和设置

对 2005 年 6 月至 2008 年 5 月期间筛查的大量全国性孕妇样本记录进行了检查。

参与者

研究包括 502,036 名孕妇,这些孕妇的胎龄信息可用。

主要措施

使用特定于检测的、特定于孕龄的参考区间来测量妊娠和产后的甲状腺功能减退症检测率和患病率。还测量了 TPOAb 和游离 T4 检测的筛查和阳性率。

结果

在 18 至 40 岁的女性中,有 23%(502,036 名中的 117,892 名)接受了妊娠期甲状腺功能减退症(定义为亚临床和显性甲状腺功能减退症)的检测。其中,15.5%(18,291 名中的 18,291 名)检测出妊娠期甲状腺功能减退症阳性。24%(93,312 名中的 22,650 名)TSH 水平正常的女性和 33%(18,291 名中的 6,072 名)TSH 水平升高的女性也接受了妊娠期甲状腺素血症的检测。在 TSH 水平正常的检测女性中,有 0.2%(22,650 名中的 47 名)检测出甲状腺素血症,在 TSH 水平升高的检测女性中,有 2.4%(6,072 名中的 144 名)检测出甲状腺素血症;0.3%(93,312 名中的 276 名)TSH 水平正常的女性接受了 TPOAb 检测,其中 15%(276 名中的 41 名)检测出阳性;66%(18,291 名中的 120 名)TSH 水平升高的女性接受了 TPOAb 检测,其中 65%(120 名中的 78 名)检测出阳性。只有 20.7%(9063 名中的 1873 名)甲状腺功能减退症女性在产后 6 个月内接受了甲状腺筛查;其中,11.5%(1873 名中的 215 名)被诊断为产后甲状腺功能减退症。

结论

妊娠甲状腺功能减退症比普遍认为的更为常见。检测并不常见,检测选择也存在差异。产后随访率较低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验